Skip to content

Dov Gertz

Chief Executive Officer at Converge Bio.

Earliest Form D on file: Apr 2026

Filed Apr 28, 2026

Converge Bio

AI antibody design for biotech and pharma teams

AI, Claymont DE

Signed as Chief Executive Officer

$25M

sold of $25M offered

Form D

LinkedIn

Network

At Converge Bio

4 people